Pastāsti draugiem par šo preci:
Benefit-Risk Assessment in Pharmaceutical Research and Development - Chapman & Hall / CRC Biostatistics Series 1. izdevums
Cena
€ 79,49
Pasūtīts no attālās noliktavas
Paredzamā piegāde . gada 24. sept. - . gada 8. okt.
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
Benefit-Risk Assessment in Pharmaceutical Research and Development - Chapman & Hall / CRC Biostatistics Series
Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D, from early clinical development to late-stage development to regulatory review to post-launch assessment. Suitable for those in b
220 pages
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2020. gada 30. jūnijs |
| ISBN13 | 9780367576240 |
| Izdevēji | Taylor & Francis Ltd |
| Lapas | 220 |
| Izmēri | 150 × 220 × 10 mm · 410 g |
| Valoda | Angļu |
| Redaktors | Felli, James |
| Redaktors | Noel, Rebecca |
| Redaktors | Sashegyi, Andreas |
